Sun Pharma Ipratropium Bromide Inhalation Solution

The product shown is a unit-dose vial of Ipratropium Bromide Ihalation Solution, a bronchodilator used to manage symptoms of respiratory conditions like COPD and asthma. This specific packaging is characteristic of generic pharmaceutical manufacturing, typically distributed in foil pouches to protect the medicine from light.

The brand belongs to Sun Pharmaceutical Industries Ltd., a multinational pharmaceutical giant founded in India. While Sun Pharma has a significant manufacturing footprint in the United States and other global regions to serve local markets like Mexico and the US, the core formulation and primary production hubs remain in India. The company has grown through strategic acquisitions to become one of the largest specialty generic pharmaceutical companies in the world.